We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics with multiple products in development, including two clinical-stage assets. Con... Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics with multiple products in development, including two clinical-stage assets. Context is headquartered in Philadelphia. Show more
Expands pipeline of T cell engaging bispecific antibodies through acquisitions of CT-95, a Mesothelin x CD3 bispecific antibody, and CT-202, a Nectin-4 x CD3 bispecific antibody Strengthens board...
PHILADELPHIA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today...
PHILADELPHIA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.41 | -29.4964028777 | 1.39 | 1.39 | 0.9606 | 294461 | 1.20120459 | CS |
4 | -0.41 | -29.4964028777 | 1.39 | 1.65 | 0.9606 | 204907 | 1.37478322 | CS |
12 | -0.87 | -47.027027027 | 1.85 | 2.5899 | 0.9606 | 271765 | 1.82116496 | CS |
26 | -1.07 | -52.1951219512 | 2.05 | 2.75 | 0.9606 | 224451 | 1.95397862 | CS |
52 | -0.1 | -9.25925925926 | 1.08 | 2.75 | 0.89 | 299571 | 1.83803911 | CS |
156 | -2.31 | -70.2127659574 | 3.29 | 3.3 | 0.47 | 409498 | 1.52067433 | CS |
260 | -3.46 | -77.9279279279 | 4.44 | 10.87 | 0.47 | 739465 | 3.6991662 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions